Elsevier,
International Environmental Cooperation and The Global Sustainability Capital Framework, 2021, Pages 1-15
This chapter discusses the need for international environmental cooperation (IEC) in a context of our common vulnerabilities and contingent survivability. It also introduces the Sustainability Capital Framework (SCF) as a core framework for guiding sustainable development, and for delimiting the boundaries of global sustainability.
This chapter advances the UN SDG goal 3 and 17 in understanding Alzheimer's disease at the cellular level
This chapter advances the UN SDG goal 3 and 17 in exploring the link between metabolites of shikimate pathway and Alzheimer disease
This book chapter advances SDGs 3 and 17 by providing an overview of the characteristic features of neurodegenerative diseases, including AD and how to assess them to validate or to reject the suspected diagnosis.
Elsevier,
Choy Yee Keong, Chapter 2 - The United Nations' journey to global environmental sustainability since Stockholm: An assessment, Editor(s): Choy Yee Keong, Global Environmental Sustainability, Elsevier, 2021, Pages 7-61
This book chapter advances SDGs 13, 15, and 17 by providing perspective on what's been done so far to address environmental sustainability globally and how the goals have developed as a response to climate change.
This book chapter advances SDGs 3 and 17 by reviewing behavioral interventions and strategies for spoken communication for people with dementia and their communication partners.
This book chapter advances SDGs 3 and 17 by reviewing research on a range of rehabilitation programmes aiming to improve the functional independence of people with dementia, such as specialist-led or multimodal rehabilitation, cognitive rehabilitation, function-focused care, and reablement.
This book chapter advances SDGs 3 and 17 by reviewing how to diagnosis mixed dementias.
This book chapter advances SDGs 3 and 17 by focusing on providing a brief overview of genes associated with sporadic (late-onset) Alzheimer's disease (AD). Despite decades of research, no current and reliable test is currently available for the diagnosis of AD. Genetic biomarkers are promising for both diagnostic tools and tailored profiling therapy.
This book chapter advances SDGs 3 and 17 by discussing available data regarding the effects of genetic variants on the clinical and pathological characteristics of “frontotemporal dementia” (FTD). The term “frontotemporal dementia” (FTD) defines a group of related diseases resulting from progressive degeneration of the temporal and frontal lobes. These areas play a significant role in decision-making, behavioral control, emotion, language, and motor functions.
